Krystal Biotech
KRYS
KRYS
90 hedge funds and large institutions have $635M invested in Krystal Biotech in 2019 Q4 according to their latest regulatory filings, with 12 funds opening new positions, 31 increasing their positions, 31 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
90
Holders Change
+5
Holders Change %
+5.88%
% of All Funds
1.78%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
12
Increased
31
Reduced
31
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
O
OrbiMed
New York
|
+$21.8M |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$11.8M |
| 3 |
Goldman Sachs
New York
|
+$4.43M |
| 4 |
Citigroup
New York
|
+$2.6M |
| 5 |
California Public Employees Retirement System
Sacramento,
California
|
+$2.4M |
Top Sellers
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$6.53M |
| 2 |
KCM
Knoll Capital Management
Miami,
Florida
|
-$4.17M |
| 3 |
AG
Artal Group
Luxembourg
|
-$3.88M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$3.05M |
| 5 |
Verition Fund Management
Greenwich,
Connecticut
|
-$2.49M |
